Formate-dependent Regulation of Cancer Metastasis

This project aims to elucidate the role of formate overflow in cancer metastasis and develop targeted therapies by investigating mitochondrial one-carbon metabolism and its signaling mechanisms.

Subsidie
€ 2.000.000
2024

Projectdetails

Introduction

Mechanisms underlying cancer metastasis are poorly understood and context dependent. An essential feature of disseminating cancer cells is metabolic plasticity, which allows cellular adaptation to changing environmental conditions along the metastatic cascade.

Discovery of Formate Overflow

I discovered in 2016 the phenomenon of formate overflow, an alternative pathway for serine catabolism via folate-mediated one-carbon (1C) cycle. Instead of using formate for nucleotide synthesis (to support proliferation), formate overflow is characterised by formate excretion from cancer cells.

Impact on Cancer Metastasis

Furthermore, I have convincingly demonstrated that mitochondrial 1C metabolism and increased extracellular formate concentrations promote cancer metastasis in a growth-independent manner. However, it remains unknown which intermediates of 1C metabolism contribute to this phenotype, how formate controls metastasis, and how it can be targeted therapeutically.

Research Objectives

To cross the current edge of knowledge, I will:

  1. Take advantage of genetic and newly developed analytical methods to dissect how the formate-dependent effects are propagated in cells.
  2. Describe intrinsic mechanisms to explain how the formate signal is relayed to promote metastasis.
  3. Exploit formate overflow for cancer cell killing by directly targeting the formate molecule.

Novel Concept and Tool Development

4M8 will explain a novel concept of how a mitochondrial metabolic signal drives cancer cells towards a pro-metastatic phenotype and how this knowledge can be translated into a signature to analyse the metabolic state in human tumour samples.

Conclusion

Finally, we will develop a novel tool to target formate directly within cancer cells. In sum, our research will shed light on an unexplored field of cancer metabolism, providing the foundation to develop novel treatment approaches against metastatic cancer, the primary cause of cancer death.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.000.000
Totale projectbegroting€ 2.000.000

Tijdlijn

Startdatum1-5-2024
Einddatum30-4-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • LUXEMBOURG INSTITUTE OF HEALTHpenvoerder

Land(en)

Luxembourg

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC STG

Intercellular trading in nucleotide metabolism: an emerging target

This project aims to identify nucleotide sources and metabolic interactions in cancer and stromal cells using single-cell multi-omics to develop targeted therapies against nucleotide-dependent tumors.

€ 1.450.000
ERC STG

Targeting the Metabolic Dependencies of Metastatic Tumor Cells

This project aims to identify and target unique amino acid dependencies in metastatic melanoma cells to develop novel therapies that prevent metastasis and improve cancer treatment outcomes.

€ 1.493.750
ERC POC

Targeting Mfrn2 to Inhibit Metastatic Cancers

This project aims to evaluate a solute carrier transporter as a drug target to inhibit metastatic growth in breast cancer, utilizing patient samples and mouse models for comprehensive analysis.

€ 150.000
ERC STG

Deciphering METAstasis of lung cancer to BRAIN and developing new therapeutic approaches via a human metastatic cascade platform

META-BRAIN aims to develop a human-based in vitro model to study cancer brain metastasis, the role of the blood-brain barrier, and create targeted drug delivery systems for effective treatment.

€ 1.500.000